New! Sign up for our free email newsletter.
Science News
from research organizations

Diabetes drug could be used to treat common heart failure syndrome

Date:
December 19, 2018
Source:
Rockefeller University Press
Summary:
Researchers have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat a common heart failure syndrome that is predicted to affect over 8 percent of people ages 65 or older by the year 2020. The study shows that metformin relaxes a key heart muscle protein called titin, allowing the heart to properly fill with blood before pumping it around the body.
Share:
FULL STORY

Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat heart failure with preserved ejection fraction (HFpEF), a condition that is predicted to affect over 8% of people ages 65 or older by the year 2020. The study, which was published December 19 in the Journal of General Physiology, shows that metformin relaxes a key heart muscle protein called titin, allowing the heart to properly fill with blood before pumping it around the body.

Nearly half of all heart failure patients are considered to have HFpEF, in which the heart can properly contract, but, because the wall of the left ventricle is stiffer than normal, it fails to fully relax between beats, reducing its capacity to fill with blood. This reduces blood supply to the rest of the body, leading to shortness of breath with exertion and difficulty exercising.

HFpEF is more common in women, and other risk factors include hypertension, old age, and obesity. Unlike other forms of heart failure, however, there are currently no drugs available to treat HFpEF.

Henk L. Granzier, Nancy Sweitzer, and colleagues at the Sarver Heart Center at the University of Arizona decided to investigate whether metformin could be an effective treatment for HFpEF because the drug has been shown to increase left ventricular dilation and lower the rate of heart failure in diabetes patients. The researchers gave metformin to mice with HFpEF-like symptoms and found that the drug reduced left ventricular stiffness, thereby improving the animals' capacity for exercise.

The researchers determined that metformin relaxes the left ventricle by making a heart muscle protein called titin more compliant. Titin acts like a molecular spring that helps the muscle recoil after it is stretched, and titin's stiffness can be tweaked by enzymes that add phosphate groups to the protein's spring-like elements. One of these elements, known as the N2B element, contains abnormally few phosphate groups in HFpEF patients, making titin extra stiff. But Granzier and colleagues found that metformin treatment increased the number of phosphate groups in the N2B element of mouse titin, causing the protein, and the heart muscle as a whole, to become more compliant.

"We therefore conclude that metformin is a potential therapy for patients with HFpEF," Granzier says. "Because the drug is already approved and well tolerated in humans, using it to target titin stiffness presents a unique opportunity for immediate translation to the clinic."


Story Source:

Materials provided by Rockefeller University Press. Note: Content may be edited for style and length.


Journal Reference:

  1. Rebecca E. Slater, Joshua G. Strom, Mei Methawasin, Martin Liss, Michael Gotthardt, Nancy Sweitzer, Henk L. Granzier. Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance. The Journal of General Physiology, 2018; jgp.201812259 DOI: 10.1085/jgp.201812259

Cite This Page:

Rockefeller University Press. "Diabetes drug could be used to treat common heart failure syndrome." ScienceDaily. ScienceDaily, 19 December 2018. <www.sciencedaily.com/releases/2018/12/181219115454.htm>.
Rockefeller University Press. (2018, December 19). Diabetes drug could be used to treat common heart failure syndrome. ScienceDaily. Retrieved July 24, 2024 from www.sciencedaily.com/releases/2018/12/181219115454.htm
Rockefeller University Press. "Diabetes drug could be used to treat common heart failure syndrome." ScienceDaily. www.sciencedaily.com/releases/2018/12/181219115454.htm (accessed July 24, 2024).

Explore More

from ScienceDaily

RELATED STORIES